Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010083843) CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/083843 International Application No.: PCT/DK2010/050016
Publication Date: 29.07.2010 International Filing Date: 26.01.2010
Chapter 2 Demand Filed: 26.10.2010
IPC:
A61K 9/22 (2006.01) ,A61K 9/36 (2006.01) ,A61K 9/20 (2006.01) ,A61K 9/28 (2006.01) ,A61K 31/485 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
22
Sustained or differential release type
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
28
Dragees; Coated pills or tablets
30
Organic coatings
36
containing carbohydrates or derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
28
Dragees; Coated pills or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
485
Morphinan derivatives, e.g. morphine, codeine
Applicants:
EGALET A/S; Lejrvej 37-41 Kirke Værløse DK-3500 Værløse, DK (AllExceptUS)
ANDERSEN, Christine [DK/DK]; DK (UsOnly)
JESPERSEN, Lillian [DK/DK]; DK (UsOnly)
LINDHARDT, Karsten [DK/DK]; DK (UsOnly)
ØVERGÅRD, Jan Martin [DK/DK]; DK (UsOnly)
LYHNE-IVERSEN, Louise Inoka [DK/DK]; DK (UsOnly)
OLSEN, Martin Rex [DK/DK]; DK (UsOnly)
CHRISTENSEN, Lars Hedevang [DK/DK]; DK (UsOnly)
HØILUND-JENSEN, Jacob Aas [DK/DK]; DK (UsOnly)
Inventors:
ANDERSEN, Christine; DK
JESPERSEN, Lillian; DK
LINDHARDT, Karsten; DK
ØVERGÅRD, Jan Martin; DK
LYHNE-IVERSEN, Louise Inoka; DK
OLSEN, Martin Rex; DK
CHRISTENSEN, Lars Hedevang; DK
HØILUND-JENSEN, Jacob Aas; DK
Agent:
HØIBERG A/S; St. Kongensgade 59A DK-1264 Copenhagen K, DK
Priority Data:
61/147,15126.01.2009US
PA 2009 0012726.01.2009DK
PA 2009 0078224.06.2009DK
Title (EN) CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY
(FR) FORMULATIONS À LIBÉRATION CONTRÔLÉE AVEC EFFICACITÉ CONTINUE
Abstract:
(EN) The present invention relates to pharmaceutical compositions, which provide controlled release of a drug. The compositions are suitable for continuous administration as they remain effective throughout the treatment regimen. The present invention also relates to the use of the compositions for preparation of a medicament for continuous treatment of an individual.
(FR) La présente invention concerne des compositions pharmaceutiques permettant la libération contrôlée d'un médicament. Lesdites compositions sont adaptées à une administration continue, puisqu'elles restent efficaces tout au long du régime de traitement. La présente invention porte également sur l'utilisation desdites compositions dans la préparation d'un médicament pour le traitement continu d'un individu.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
IL214274EP2389169CA2750400EP2700400NZ594071AU2010206376
IN5444/CHENP/2011